SO
CGON icon

STRS Ohio’s CG Oncology CGON Stock Holding History

STRS Ohio’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
20,800
+14,200
+215% +$928K 0.01% 603
2026
Q1 		$447K Buy
+6,600
New +$374K ﹤0.01% 1140
2024
Q2 		– Sell
-4,100
Closed -$179K – 1977
2024
Q1 		$179K Buy
+4,100
New +$167K ﹤0.01% 1585

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

STRS Ohio's CGON Position: Q2 2026 in Review

STRS Ohio increased its CG Oncology (CGON) stake by 215% in Q2 2026, buying an estimated $928K and bringing the position to 20,800 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #603.

STRS Ohio first reported a position in CGON in Q1 2024 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • STRS Ohio held 20,800 shares of CG Oncology worth $1.48M as of Q2 2026.
  • STRS Ohio bought 14,200 CG Oncology shares in Q2 2026, an estimated $928K.
  • CG Oncology made up 0.01% of STRS Ohio's portfolio in Q2 2026, its #603 holding.
  • STRS Ohio first reported a position in CG Oncology in Q1 2024 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.